Skip to main content
Article thumbnail
Location of Repository

Fluorodeoxyglucose-positron emission tomography/computed tomography in the staging and evaluation of treatment response in a patient with Castleman's disease: a case report

By Ettore Pelosi, Andrea Skanjeti, Angelina Cistaro and Vincenzo Arena
Topics: Case Report
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2001). H: F-18 fluorodeoxyglucose positron emission tomography in mesenterial Castleman's lymphoma. Clin Nucl Med
  2. (1997). Karwal MW: FDG-PET appearance of pelvic Castleman's disease.
  3. (2003). MM: FDG positron emission tomographic imaging of thoracic Castleman's disease. Clin Nucl Med
  4. (2001). Mortelmans L: FDG positron emission tomographic scintigraphy can reveal Castleman's disease as a cause of inflammation. Clin Nucl Med
  5. (2007). Peterson BA: Castleman disease. Curr Opin Hematol
  6. (1954). Towne VW: Case records of the Massachusetts General Hospital: case 40011.
  7. (2007). Unicentric and multicentric Castleman's disease.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.